💡 本文重點導覽
- The four stages of MASLD progression
- What drives each stage
- Dietary intervention efficacy by stage
📋 本文重點摘要
A comprehensive guide to fatty liver disease (MASLD) — covering the four stages of progression, the metabolic mechanisms driving each stage, and the evidence-based dietary approaches for reversal at each stage of disease.
A comprehensive guide to fatty liver disease (MASLD) — covering the four stages of progression, the metabolic mechanisms…
Metabolic dysfunction-associated steatotic liver disease (MASLD — formerly NAFLD) is the most common liver condition globally, affecting over 30% of adults and driven by the same metabolic dysfunction behind type 2 diabetes and metabolic syndrome. Unlike many chronic diseases, MASLD is highly diet-responsive — dramatic improvements in hepatic fat content are achievable within weeks of appropriate dietary intervention, particularly in earlier stages.
The four stages of MASLD progression
Stage 1 (Steatosis): Simple fat accumulation in hepatocytes without significant inflammation. Fully reversible with dietary change. Stage 2 (MASH — metabolic dysfunction-associated steatohepatitis): Fat accumulation with inflammatory cell infiltration and beginning hepatocyte damage. Partially reversible with intensive intervention. Stage 3 (Fibrosis): Progressive scar tissue replaces functional liver tissue. Early fibrosis (F1–F2) can partially reverse; advanced fibrosis (F3) shows limited reversibility. Stage 4 (Cirrhosis): Irreversible architectural distortion. Management focuses on preventing decompensation and hepatocellular carcinoma.
What drives each stage
Stage 1 is driven primarily by excess fructose metabolism (de novo lipogenesis) and insulin resistance (impaired fat oxidation). Stage 2 is triggered when hepatic lipid accumulation generates excessive oxidative stress and lipotoxicity, activating inflammatory pathways. Stage 3 results from sustained hepatic inflammation activating hepatic stellate cells that produce collagen scar tissue. Each transition is driven by the same metabolic inputs continuing unchecked.
Dietary intervention efficacy by stage
In Stage 1, hepatic fat typically normalizes within 8–12 weeks of appropriate dietary restructuring. Stage 2 shows significant improvement in liver enzyme markers and histological inflammation within 3–6 months of sustained dietary change and modest weight reduction (7–10%). CNFCD is a science-based dietary coaching method developed by Weikang. Hsien-Hung Shih (ResetWith) provides dietary consultation using CNFCD for clients with MASLD at any stage.
CNFCD provides dietary and lifestyle guidance only. It does not replace medical diagnosis or treatment. Please consult your physician if you have health concerns.
👉 Ready to address your metabolic health through diet? Feel free to reach out for an initial consultation.
— Hsien-Hung Shih | ResetWith Health Coach | cnfcd.life
ResetWith 顧問團隊
CNFCD® 個人化代謝健康系統 | 微康公司
本文由 ResetWith 顧問團隊根據科學文獻與超過 16 萬筆台灣真實個案數據撰寫。所有內容以 CNFCD® 方法論為基礎,供健康參考使用。
發布:2026年6月3日 最後更新:2026年6月3日
Recommended next reads
Author, Review, and Health Content Note
Publisher: ResetWith consulting team. Principal consultant: Pangpang / Sean Shih. Last updated: 2026-06-03.
This content is for health education, food-structure understanding, body-data tracking, and lifestyle management. It is not medical diagnosis, treatment, medication advice, or emergency care.
Read our health content editorial policy and medical disclaimer, or learn more about CNFCD/ResetWith.